METACARE CO., Ltd. (KRX:118000)
South Korea · Delayed Price · Currency is KRW 330.00
-1.00 (-0.30%)
At close: Jul 25, 2025, 3:30 PM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 56.69 billion as of July 25, 2025. Its market cap has decreased by -13.88% in one year.
Market Cap
56.69B
Enterprise Value
94.04B
Revenue
21.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
330.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has increased from 39.82B to 56.69B, an increase of 42.37%. That is a compound annual growth rate of 2.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 56.69B | 21.99% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | 143.38B | 61.54% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.73T |
| Celltrion | 39.71T |
| ALTEOGEN | 25.60T |
| Yuhan | 9,359.37B |
| SK Biopharmaceuticals | 7,964.46B |
| Peptron | 6,907.66B |
| HLB Co., Ltd. | 6,558.63B |
| PharmaResearch | 6,057.16B |